Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1 (ALS-PDC1)

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1(来自ICD-11)

别称:

Guam Disease

Lytico-Bodig Disease

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex of Guam

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1, Susceptibility to

Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex

Parkinson-Dementia Complex of Guam

Guam Parkinsonism-Dementia Complex

Als-Pdc

G-Pdc

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex, Susceptibility to

Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia of Guam Syndrome

Sclerosis, Lateral, Amyotrophic/parkinsonism/dementia Complex 1

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex

Amyotrophic Lateral Sclerosis, Guam Form

Parkinsonism-Dementia-Als Complex

Amyotrophic Lateral Sclerosis

Parkinsonian Disorders

Als/pdc of Guam

Als-Pdc1

Pdals

加入收藏

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1, also known as guam disease, is related to frontotemporal dementia and/or amyotrophic lateral sclerosis 4 and amyotrophic lateral sclerosis 19, and has symptoms including tremor, bradykinesia and abnormality of extrapyramidal motor function. An important gene associated with Amyotrophic Lateral Sclerosis-Parkinsonism/dementia Complex 1 is TRPM7 (Transient Receptor Potential Cation Channel Subfamily M Member 7), and among its related pathways/superpathways are Neuroscience and Copper homeostasis. The drugs Olanzapine and Risperidone have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and spinal cord, and related phenotypes are cerebral atrophy and dementia

查看原文参与反馈